The arcuate nucleus (ARC) of the hypothalamus is a critical integrative center that regulates energy homeostasis, neuroendocrine function, and autonomic processes. It serves as a master regulator linking metabolic status to neural and endocrine responses, with emerging roles in neurodegenerative disease pathophysiology. [1]
| Property | Value | [2]
|----------|-------| [3]
| Location | Median eminence, mediobasal hypothalamus | [4]
| Marker Genes | NPY, AgRP, POMC, CART, Kisspeptin | [5]
| Neurotransmitters | NPY, α-MSH, AgRP, GABA, Glutamate | [6]
| Key Functions | Energy balance, HPA axis, GH/Prolactin regulation | [7]
| Database | ID | Name | Confidence | [8]
|----------|----|------|------------|
| Cell Ontology | CL:1001135 | arcuate artery cell | Medium |
| Cell Ontology | CL:1001142 | arcuate vein cell | Medium |
| Cell Ontology | CL:1001213 | arcuate artery endothelial cell | Medium |
| Taxonomy | ID | Name / Label |
|---|---|---|
| Cell Ontology (CL) | CL:1001135 | arcuate artery cell |
The arcuate nucleus contains distinct neuronal populations:
ARC integrates metabolic signals:
NPY/AgRP neurons:
POMC neurons:
Growth Hormone: GHRH neurons regulate GH secretion
Prolactin: TIDA neurons inhibit prolactin release
Reproduction: Kisspeptin neurons control GnRH release
ARC modulates:
ARC dysfunction contributes to AD pathophysiology:
Metabolic Syndrome Link: Mid-life obesity and metabolic syndrome increase AD risk, with ARC-mediated inflammation playing a role 1.
HPA Axis Dysregulation: ARC-driven cortisol excess in chronic stress accelerates hippocampal degeneration 2.
Leptin Resistance: ARC neurons become leptin-resistant in AD, disrupting metabolic signaling and potentially affecting amyloid clearance 3.
Inflammation: ARC activation drives neuroinflammatory cascades through microglial modulation 4.
Metabolic Disturbances: ARC dysfunction contributes to weight loss and metabolic abnormalities in PD 5.
Melatonin Dysregulation: ARC connects to pineal gland; impaired signaling contributes to sleep disturbances 6.
Autonomic Failure: ARC-mediated autonomic control is compromised in PD, contributing to orthostatic hypotension.
Hypermetabolism: ARC dysregulation contributes to the hypermetabolic state observed in ALS 7.
Stress Response: Altered HPA axis function affects disease progression.
Nutritional Support: Understanding ARC function guides nutritional interventions.
Metabolic Abnormalities: Early ARC dysfunction contributes to weight loss despite hyperphagia in HD 8.
HPA Axis: Dysregulated cortisol signaling affects neurodegeneration.
While not a neurodegenerative condition, PWS shows ARC dysfunction:
Leptin Sensitizers: Restore ARC leptin signaling 9.
Melanocortin Agonists: MC4R agonists for energy homeostasis
Anti-inflammatory agents: Reduce ARC-mediated neuroinflammation
BDNF modulation: POMC neurons produce BDNF; enhancing this pathway may be neuroprotective 10.
Metabolic support: Optimize mitochondrial function in ARC neurons
The study of Arcuate Nucleus (Arc) Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Martins et al. Metabolic syndrome and AD risk (2016). 2016. ↩︎
Leptin and AD (2014). 2014. ↩︎
Metabolism in PD (2012). 2012. ↩︎
Melatonin and PD (2017). 2017. ↩︎
Metabolism in ALS (2018). 2018. ↩︎
BDNF and POMC neurons (2018). 2018. ↩︎